Open, Multicentric, Prospective, Quality of Life Study in Multiple Sclerosis Patients

NCT00928967 · clinicaltrials.gov ↗

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Interferon beta-1b, (Betaseron BAY86-5046)

Sponsor

Bayer